Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Grundmann

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Nutrients|March 26, 2022
Vitamin C Plasma Levels Associated with Inflammatory Biomarkers, CRP and RDW: Results from the NHANES 2003-2006 SurveysJennifer Marie Crook, Ann L Horgas, Saunjoo L Yoon, et al.
Journal of Ethnopharmacology|September 17, 2025
Prevalence and use patterns of kava (Piper methysticum) in a US nationally representative sampleJessica Mamallapalli, Allison Henderson, Erin Berthold, et al.
Journal of Psychoactive Drugs|April 10, 2019
Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance UsersKirsten E Smith, Amanda M Bunting, Robert Walker, et al.
Frontiers in Pharmacology|September 13, 2021
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United StatesWalter C Prozialeck, Peter C Lamar, Michael Krupp, et al.
Frontiers in Pharmacology|July 1, 2024
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveysJeffrey M Rogers, Kayla Colvin, David H Epstein, et al.
Drug and Alcohol Dependence|May 24, 2024
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequencyJeffrey M Rogers, Stephanie T Weiss, David H Epstein, et al.
Substance Abuse|February 18, 2022
How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media dataOliver Grundmann, Charles A Veltri, Diana Morcos, et al.
American Journal of Pharmaceutical Education|August 11, 2020
The Pharmacist as an LGBTQ AllyOliver Grundmann, Richard Segal, Joshua Pullo, et al.
Journal of Addiction Medicine|November 19, 2024
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication-related MortalityArmiel A Suriaga, Ruth M Tappen, Christopher R McCurdy, et al.
Frontiers in Psychiatry|December 17, 2020
Can Kratom (<i>Mitragyna speciosa</i>) Alleviate COVID-19 Pain? A Case StudyAntonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Nutrients|March 26, 2022
Vitamin C Plasma Levels Associated with Inflammatory Biomarkers, CRP and RDW: Results from the NHANES 2003-2006 SurveysJennifer Marie Crook, Ann L Horgas, Saunjoo L Yoon, et al.
Journal of Ethnopharmacology|September 17, 2025
Prevalence and use patterns of kava (Piper methysticum) in a US nationally representative sampleJessica Mamallapalli, Allison Henderson, Erin Berthold, et al.
Journal of Psychoactive Drugs|April 10, 2019
Non-Prescribed Buprenorphine Use Mediates the Relationship between Heroin Use and Kratom Use among a Sample of Polysubstance UsersKirsten E Smith, Amanda M Bunting, Robert Walker, et al.
Frontiers in Pharmacology|September 13, 2021
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United StatesWalter C Prozialeck, Peter C Lamar, Michael Krupp, et al.
Frontiers in Pharmacology|July 1, 2024
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveysJeffrey M Rogers, Kayla Colvin, David H Epstein, et al.
Drug and Alcohol Dependence|May 24, 2024
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequencyJeffrey M Rogers, Stephanie T Weiss, David H Epstein, et al.
Substance Abuse|February 18, 2022
How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media dataOliver Grundmann, Charles A Veltri, Diana Morcos, et al.
American Journal of Pharmaceutical Education|August 11, 2020
The Pharmacist as an LGBTQ AllyOliver Grundmann, Richard Segal, Joshua Pullo, et al.
Journal of Addiction Medicine|November 19, 2024
The Associations of Kratom (Mitragynine), Opioids, Other Substances, and Sociodemographic Variables to Drug Intoxication-related MortalityArmiel A Suriaga, Ruth M Tappen, Christopher R McCurdy, et al.
Frontiers in Psychiatry|December 17, 2020
Can Kratom (<i>Mitragyna speciosa</i>) Alleviate COVID-19 Pain? A Case StudyAntonio Metastasio, Elisabeth Prevete, Darshan Singh, et al.
Pageof 13